Skip to main content

Table 3 Laboratory parameters among the 3 studied groups

From: Helicobacter pylori infection in patients with metabolic syndrome, with or without nonalcoholic fatty liver disease

  Total N = 300 Control N = 100 Metabolic with NAFLD N = 100 Metabolic without NAFLD N = 100 Test of significance Within group significance
Serum cholesterol (mg/dl) 148.40 ± 48.64 94.9 ± 20.9 183.34 ± 29.20 166.92 ± 37.27 F = 247.6
P < 0.001*
p1 = 0.001*
p2 = 0.001*
p3 = 0.001*
TGS (mg/dl) 164(50-739) 100.0 (50–300) 204 (140–739) 172 (110–388) KW
P < 0.001*
p1 < 0.001*
p2 < 0.001*
p3 < 0.001*
LDL (mg/dl) 98.32 ± 28.9 88.10 ± 13.26 108.13 ± 39.67 98.73 ± 24.1 F = 12.93
P < 0.001*
p1 = 0.001*
p2 = 0.007*
p3 = 0.01*
HDL (mg/dl) 40.51 ± 6.82 44.99 ± 3.99 36.67 ± 6.98 39.86 ± 6.34 F = 50.38
P < 0.001*
p1 < 0.001*
p2 < 0.001*
p3 < 0.001*
ALT (mg/dl) 40 (10–163) 40 (30–98) 87 (12–163) 50 (10–70) KW
P < 0.001*
p1 < 0.001*
p2 < 0.001*
p3 = 0.01*
Fasting blood glucose (mg/dl) 112 (70–500) 80 (70–102) 200 (70–500) 160 (70–436) KW
P < 0.001*
p1 < 0.001*
p2 < 0.001*
p3 = 0.009*
S. creatinine (mg/dl) 1.08 ± 0.42 1.124 ± 0.23 1.10 ± 0.50 1.02 ± 0.46 F = 1.75
P = 0.18
p1 = 0.68
p2 = 0.07
p3 = 0.17
  1. *One subject of the control group had TGs level of 300 but it was discovered accidentally by us, and she has no complain and no past medical history that is why she was involved. (Note that all subjects of control group had no past medical history)